Meet the Immunocine Team: Dr. Gregorio Viramontes
READ THIS NEXT
Metastatic Melanoma: A Deep Dive into the Aggressive Form of Skin Cancer
Melanoma, a type of skin cancer, can be a frightening diagnosis. But within the spectrum of melanoma, metastatic melanoma stands out as particularly aggressive and challenging to treat. In this article, we’ll explore what sets metastatic melanoma apart, its seriousness, conventional treatment approaches, the promising role of immunotherapy, and the intriguing connection with dendritic cell …
Read More
Why don’t Checkpoint Inhibitors Work More Often?
With immunotherapy really taking off in the past decade, many cancer patients are rightfully interested in adding this potential modality to their treatment plan. After all, it has long been established that the immune system can eliminate cancer if properly educated1, 2 and powered3, and that this is not dependent on where or what started the …
Read More
Immunotherapy vs. Chemotherapy Side Effects: Comparing the Objectives
On August 4th, we posted an overview of how chemotherapeutic side effects differ from those experienced during immunotherapy. Informative, but broad, we decided to dive a little deeper into what really drives those effects and when they can even be beneficial.
Read More
